CN
399-51-9
应用筛选条件
关键词:'399-51-9'
显示 1-30 共 107 条结果 关于 "399-51-9" 范围 技术文档
Data Sheet - H6661
factors. Kidney Int., 51, 567-574 (1997).
4. Maxwell, P. H., et al., The tumor suppressor protein
VHL targets hypoxia-inducible factors for oxygen-
dependent proteolysis. Nature, 399, 271-275
(1999).
Data Sheet - H6411
factors. Kidney Int., 51, 567-574 (1997).
4. Maxwell, P. H., et al., The tumor suppressor protein
VHL targets hypoxia-inducible factors for oxygen-
dependent proteolysis. Nature, 399, 271-275
(1999).
Data Sheet - H6536
factors. Kidney Int., 51, 567-574 (1997).
4. Maxwell, P.H., et al., The tumor suppressor protein
VHL targets hypoxia-inducible factors for oxygen-
dependent proteolysis. Nature, 399, 271-275
(1999).
Product Information Sheet-endoglus-ro
diagnostic procedures.
y Version: 21
Content Version: November 2020
Lyophilized
Cat. No. 11 420 399 001 50 μg
Cat. No. 11 047 817 001 3 x 50 μg
Store the product at +2
Citrate Azide Tween®Carbonate (CATC) Agar
of phylogenetically distinct enterococcal species and species groups. J. Appl.
Bacteriol. 75: 399-408.
Pharmacopoeia of Culture Media for Food Microbiology (1987): Int. J. Food Microbiol. 5: 214
Product Information Sheet - 99314
1983).
9 Evidence for an amiloride sensitive Na+ pathway in the amphibian diluting segment induced by K+ adaptation. H.
Oberleithner, F. Lang, W. Wang, G. Messner, P. Deetjen, Pflügers Arch. 399, 166 (
Datasheet - 146321
differentiation of phylogenetically distinct enterococcal species and
species groups. J. Appl. Bacteriol. 75: 399-408.
DIN EN ISO 7899-2 (2000): Water quality - Detection and enumeration of intestinal
enterococci
Anti-BACE-2 C-terminus (501-518) antibody produced in rabbit (B8060)
identified and termed BACE-2, (also termed Asp1,
DRAP or memapsin 1).9-11 BACE-1 and BACE -2 have
similar structural organization and share 51% amino
acid sequence identity. BACE-1 is highly expressed in
Anti-BACE-2 N-terminus (43-60) antibody produced in rabbit (B7935)
also identified and termed
BACE-2, (Asp1, DRAP or Memapsin 1).9-11 BACE-1
and BACE-2 have similar structural organization and
share 51% amino acid sequence identity. BACE-1 is
highly expressed in neurons
CH12.LX Mouse Lymphoma Cell Line
Natl Acad Sci USA. 1986; 83(19): 7410-7414.
3. J Immunotoxicol. 2012; 9(2): 129-140.
4. Scand J Immunol. 2000; 51(4): 392-399.
FOR RESEARCH USE ONLY.
NOT FOR USE IN DIAGNOSTIC PROCEDURES.
XP725 Antibody Number-Lot Number 071M4826
a-b c-d e-f g-h a-b c-d e-f g-h
1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78
Product Information Sheet - F4375
W.S. et al., J. Immunol. Methods, 29, 1
(1979).
6. Niskanen, E. et al., Cell Tissue Kinet., 18, 399
(1985).
7. Sambrook, J. et al., Molecular Cloning: A
Laboratory Manual, Cold Spring Harbor
Ficoll 400 - Product Information Sheet (F4375)
. et al., J. Immunol. Methods,
29, 1 (1979).
6. Niskanen, E. et al., Cell Tissue Kinet., 18,
399 (1985).
7. Sambrook, J. et al., Molecular Cloning: A
Laboratory Manual, Cold Spring Harbor
Laboratory
Product Information Sheet - 11373099910
reactions 11 636 090 910
Product Pack size Cat. No.
Protector RNase Inhibitor 2000 U
10 000 U
03 335 399 001
03 335 402 001
Blocking reagent 50 g 11 096 176 001
CDP-Star, ready -to-use 2× 50 ml 12
Product Information Sheet - 11526529910
reactions 11 636 090 910
Product Pack size Cat. No.
Protector RNase Inhibitor 2000 U
10 000 U
03 335 399 001
03 335 402 001
Blocking reagent 50 g 11 096 176 001
CDP-Star, ready -to-use 2× 50 ml 12
Product Information Sheet - 11526537910
reactions 11 636 090 910
Product Pack size Cat. No.
Protector RNase Inhibitor 2000 U
10 000 U
03 335 399 001
03 335 402 001
Blocking reagent 50 g 11 096 176 001
CDP-Star, ready -to-use 2× 50 ml 12
Product Information Sheet - SH1921
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH2521
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH1021
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH0721
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH2421
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH1821
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH0221
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH2221
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH2321
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH0521
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH1321
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH0421
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH2821
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
Product Information Sheet - SH0821
Sun, Y., Overview of approaches for screening for
ubiquitin ligase inhibitors. Methods Enzymol., 399,
654-63 (2005).
4. Hershko, A., The ubiquitin system for protein
degradation and some of its
1/4